Search the Newsreel

NeoGenomics (NEO) stake tops 8% for First Light’s Mathew Arens

Mathew P. Arens and First Light Asset Management, LLC have reported their beneficial ownership in NeoGenomics, Inc. through a Schedule 13G/A filing. Arens beneficially owns 8.37% of NeoGenomics' common stock, totaling 10,759,586 shares, which includes holdings through First Light, direct shares, and a joint …

California State Teachers Retirement System Raises Position in NeoGenomics, Inc. $NEO

The California State Teachers Retirement System significantly increased its stake in NeoGenomics, Inc. (NASDAQ:NEO) by 56.8% in the first quarter, now owning 194,103 shares valued at $1.44 million. This move is reflective of a broader positive sentiment from institutional investors, who collectively own 98.5% …

NeoGenomics Senior VP & Chief Accounting Officer Gregory Aunan Sells 80% Of Holding

NeoGenomics' Senior VP & Chief Accounting Officer, Gregory Aunan, recently sold US$321k worth of shares, representing an 80% reduction in his holdings at an average price of US$16.07. This significant insider selling event, occurring slightly below the current share price of US$16.53, raises caution …

Renaissance Technologies LLC Acquires New Shares in NeoGenomics, Inc. $NEO

Renaissance Technologies LLC has acquired 254,172 shares of NeoGenomics, Inc. (NASDAQ:NEO) worth approximately $1.89 million, increasing institutional ownership of the company to 98.5%. This comes as NeoGenomics exceeded Q1 earnings expectations with $0.05 EPS and $201.66 million in revenue, an 11.2% year-over-year increase. Analysts …

Will Narrowing Losses, 2027 Guidance and Buybacks Change Neogen's (NEOG) Narrative?

Technical Reactions to NEO Trends in Macro Strategies

This article provides a technical analysis of Neogenomics Inc. (NYSE: NEO) based on AI models, indicating strong sentiment across all time horizons and compelling upside potential. It outlines three distinct trading strategies (Position, Momentum Breakout, and Risk Hedging) with specific entry, target, and stop-loss …

Form 8K NeoGenomics Inc For: 11 August By Investing.com

This article reports on NeoGenomics Inc.'s Form 8K filing for August 11th. The brief notice confirms the filing, and the article is primarily a placeholder for this regulatory update. No specific details about the content of the 8K filing are provided within this particular …

NeoGenomics announces planned departure of General Counsel Alicia Olivo

NeoGenomics, Inc. announced that Alicia Olivo, Executive Vice President, General Counsel, and Business Development, will depart from her role as General Counsel effective September 21, 2026, and will assist with the transition until October 2, 2026. This news follows the company's strong second-quarter 2026 …

Neogen Corporation (NEOG) Stock Price, News, Quote & History

Neogen Corporation (NEOG) stock closed at $11.49, up 0.79% on August 11, 2026, with an after-hours price of $11.55. The company specializes in food and animal safety products and has shown significant year-to-date and one-year returns of 64.38% and 124.85% respectively. Analysts have an …

Surging Earnings Estimates Signal Upside for Neogen (NEOG) Stock

Neogen (NEOG) Q4 2026 Earnings Call Transcript

Neogen Corporation (NEOG) Stock Forecasts

Argus has raised its target price for Neogen Corporation (NEOG) to $12.00, citing the company's focus on food and animal safety products. Neogen, based in Lansing, Michigan, develops, manufactures, and markets these products. The report provides a summary of the company and suggests upgrading …

Is Neogen (NEOG) Still Undervalued After Flat Earnings And New Guidance?

MFG Wealth Management Inc. Takes Position in NeoGenomics, Inc. $NEO

MFG Wealth Management Inc. has initiated a position in NeoGenomics, Inc. (NASDAQ:NEO) by purchasing 83,462 shares valued at approximately $1.22 million, representing about 0.06% of the company. Institutional investors and hedge funds collectively own 98.5% of NeoGenomics, which has received a "Moderate Buy" consensus …

NeoGenomics Appoints Carolyn Starrett to its Board of Directors

NeoGenomics, Inc. has appointed Carolyn Starrett to its Board of Directors. Ms. Starrett brings over 25 years of experience in commercial, product, and operations roles at data and technology companies, with significant expertise in AI and data insights in cancer care. Her appointment is …

Neogenomics stock hits 52-week high at 16.46 USD

NeoGenomics Inc. (NEO) stock has reached a 52-week high of $16.46, driven by strong investor confidence and recent positive financial results. Despite being considered overvalued by InvestingPro analysis, the company's stock has delivered a 170% return over the past year, with analysts predicting profitability …

NeoGenomics (NEO) Is Up 8.4% After Q2 Profit Return And Raised 2026 Outlook – Has The Bull Case Changed?

NeoGenomics (NEO) reported a return to quarterly profitability in Q2 2026 with revenue of US$201.66 million and a net income of US$2.24 million, a significant improvement from a net loss the previous year. Management also narrowed its expected full-year 2026 net loss and slightly …

Dimensional Fund Advisors LP Buys 225,588 Shares of NeoGenomics, Inc. $NEO

Dimensional Fund Advisors LP increased its stake in NeoGenomics, Inc. (NASDAQ:NEO) by 9.2% in the first quarter, purchasing an additional 225,588 shares, bringing its total holdings to 2.67 million shares valued at approximately $19.8 million. This acquisition reflects a broader institutional interest in NeoGenomics, …

NeoGenomics, Inc. $NEO Stock Position Raised by Sei Investments Co.

Sei Investments Co. significantly increased its stake in NeoGenomics, Inc. (NASDAQ:NEO) by 320.7% during the first quarter, now holding 466,199 shares valued at $3.46 million. This move is mirrored by other institutional investors, collectively owning 98.5% of the company's stock, despite a recent insider …

How NeoGenomics’ Q2 Profit Return And Higher 2026 Outlook At NeoGenomics (NEO) Has Changed Its Investment Story

NeoGenomics (NEO) reported a return to profitability in Q2 2026 with US$2.24 million net income and raised its full-year 2026 revenue outlook to US$802 million–US$806 million, indicating improving operational performance. This positive shift strengthens the company's investment narrative, emphasizing its role as a specialized …

NeoGenomics, Inc. Revenue Breakdown – BX:NG9

NeoGenomics, Inc. (BX:NG9) generated 576.61 million CHF in revenue last year. The "Client Direct Billing" segment was the top performer, contributing 411.32 million CHF, a decrease from the previous year. The United States was the primary regional contributor, accounting for all of the company's …

Neogen Corp (NASDAQ: NEOG) CEO notes son's indirect buy of 370 shares

Neogen Corp CEO Mikheal Nassif reported an indirect purchase of 370 shares of Common Stock at $11.81 per share on August 4, 2026. The shares are held by his son, bringing the reported indirect holdings to 1,074 shares, though Nassif disclaims beneficial ownership. This …

Neogen CEO Mikheal Nassif buys $4,369 in company stock

Mikheal Nassif, CEO of NEOGEN CORP (NASDAQ:NEOG), recently purchased 370 shares of company stock for $4,369, increasing his indirect beneficial ownership to 1,074 shares held by his son. This transaction follows Neogen's strong fiscal fourth-quarter performance, which exceeded revenue and earnings estimates, contributing to …

Arrowstreet Capital Limited Partnership Buys New Position in Neogen Corporation $NEOG

Arrowstreet Capital Limited Partnership has acquired a new stake in Neogen Corporation, purchasing 320,808 shares valued at approximately $2.98 million, increasing institutional ownership to 96.73%. This move comes as analyst sentiment for Neogen is mixed, with a consensus "Hold" rating and a target price …

NEOG Reiterated by Piper Sandler -- Price Target Raised to $13.0

Piper Sandler has reiterated a "Neutral" rating for Neogen (NEOG) and increased its price target from $11.00 to $13.00, reflecting cautious optimism despite the stock appearing overvalued according to GuruFocus's GF Value. Neogen, a company focused on food and animal safety, shows fair overall …

NeoGenomics, Inc. (NEO) Hit a 52 Week High, Can the Run Continue?

NeoGenomics, Inc. (NEO) recently hit a new 52-week high, with its stock up 4.5% in the past month and 34.7% since the start of the year. This outperformance is attributed to strong earnings surprises, with expected EPS growth of 50% for the current fiscal …

Medical Devices & Supplies - Diversified Stocks Q2 Results: Benchmarking Neogen (NASDAQ:NEOG)

NEO5107997 Bond Profile — Key Metrics

This article provides key metrics for the NEO5107997 bond issued by NeoGenomics, Inc. It details the bond's coupon rate, issue and maturity dates, outstanding amount, and face value. The profile also includes a brief description of NeoGenomics, Inc., a clinical laboratory company specializing in …

NeoGenomics (NEO) Following Q2 Profit And Raised Outlook, Is Fair Value Already Priced In?

NEO Stock Price and Chart — NASDAQ:NEO

This article provides a comprehensive overview of NeoGenomics, Inc. (NASDAQ: NEO), including its stock price performance, key financial metrics, recent earnings report, and analyst ratings. It highlights the company's Q2 2026 revenue growth and increased full-year guidance. The article also includes various trading ideas …

NEOGEN CORP FY 2026: Revenue $870.4M, Net loss $7.9M, EPS $(0.04) — 10-K Summary

NEOGEN CORP reported its fiscal year 2026 results, with revenue reaching $870.4 million and a net loss of $7.9 million, resulting in a diluted loss per share of $(0.04). While revenue decreased by 3% from the prior year, the company significantly narrowed its net …

Neogen Corp reports results for the quarter ended May 31 - Earnings Summary

Neogen Corp has reported its earnings results for the quarter that ended on May 31. The article provides an earnings summary from Reuters, accessible to TradingView users with unlimited access. The full article content requires a subscription to view.

Why Neogen (NEOG) Is Up 28.1% After Issuing 2027 Guidance And Narrowing Annual Losses